Pembroke Pines, FL (PRWEB) April 28, 2009
NextWave Research announces the initiation of research coverage for Endologix (Nasdaq: ELGX) with a Strong Buy rating and $4.50 price target. The complete research report is available free of charge at http://www.NextWaveResearch.com
The research report written by John M. Putnam, CFA describes Endologix's four new product approvals from the U.S. Food and Drug Administration, which open new segments of the Abdominal Aortic Aneurysm (AAA) market and improve the ease-of-use of its entire product portfolio. The new products include: the Powerlink XL which can be used to treat large aortic necks; suprarenal proximal extensions for treating difficult aortic neck anatomies; and the IntuiTrak and IntuiTrak Express delivery systems which make placement of the implants easier and more rapid than competitive products. The new products will address an incremental $70 million market segment in the U.S. and contribute to Endologix's revenue growth which was 43% Year over Year in the recently reported Q1.
Mr. Putnam states "Endologix's products address a large and growing market with the world-wide market over $700 million and growing at 9% CAGR. Aortic Aneurysms are age related with over 2 million older Americans affected and 200,000 new cases diagnosed annually, resulting in approximately 60,000 procedures being performed each year. The treatment of an AAA is not elective and is therefore immune to economic conditions. At some stage, the aneurysm becomes too large to be ignored and requires immediate attention or a rupture and almost certain death will occur." He further believes that the company is financially strong and on the verge of becoming operating cash flow positive in the current quarter and profitable by the end of 2009 or early in 2010.
NextWave Research founder, Stephen M. Dunn states "Investors should always look for companies that continue to develop and innovate, especially during difficult economic times. Those companies often become the new leaders when the financial situation begins to improve."
Interested readers can access the complete research report and all of NextWave Research's analysis free-of-charge at http://www.NextWaveResearch.com with articles available in 11 languages.
About NextWave Research:
NextWave Research was created to address the dearth of professional Wall Street research coverage for quality small-cap companies. We believe that quality companies who choose to sponsor research analyst coverage provide a desperately needed service to both individual and institutional investors with reports and commentary freely available to all. We Don't Get Paid to Like Companies-We Get Paid by Companies We Like™.